Global Hydromorphone Market Research Report 2024
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Oral
Injection
Segment by Application
Hospital
Drug Store
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Purdue Pharma
Akorn
Barr Pharmaceuticals
Pfizer
Watson Laboratories
Mallinckrodt
Teva Pharmaceuticals
KV Pharmaceutical
Lannett
Apotex
Fresenius
Johnson and Johnson
Mundipharma
Novartis
Stada Arzneimittel
Mylan

Table of Content
1 Hydromorphone Market Overview
1.1 Product Overview and Scope of Hydromorphone
1.2 Hydromorphone Segment by Type
1.2.1 Global Hydromorphone Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Oral
1.2.3 Injection
1.3 Hydromorphone Segment by Application
1.3.1 Hydromorphone Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Hydromorphone Market Size Estimates and Forecasts
1.4.1 Global Hydromorphone Revenue 2016-2027
1.4.2 Global Hydromorphone Sales 2016-2027
1.4.3 Hydromorphone Market Size by Region: 2016 Versus 2021 Versus 2027
2 Hydromorphone Market Competition by Manufacturers
2.1 Global Hydromorphone Sales Market Share by Manufacturers (2016-2021)
2.2 Global Hydromorphone Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Hydromorphone Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Hydromorphone Manufacturing Sites, Area Served, Product Type
2.5 Hydromorphone Market Competitive Situation and Trends
2.5.1 Hydromorphone Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Hydromorphone Players Market Share by Revenue
2.5.3 Global Hydromorphone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hydromorphone Retrospective Market Scenario by Region
3.1 Global Hydromorphone Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Hydromorphone Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Hydromorphone Market Facts & Figures by Country
3.3.1 North America Hydromorphone Sales by Country
3.3.2 North America Hydromorphone Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Hydromorphone Market Facts & Figures by Country
3.4.1 Europe Hydromorphone Sales by Country
3.4.2 Europe Hydromorphone Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Hydromorphone Market Facts & Figures by Region
3.5.1 Asia Pacific Hydromorphone Sales by Region
3.5.2 Asia Pacific Hydromorphone Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Hydromorphone Market Facts & Figures by Country
3.6.1 Latin America Hydromorphone Sales by Country
3.6.2 Latin America Hydromorphone Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Hydromorphone Market Facts & Figures by Country
3.7.1 Middle East and Africa Hydromorphone Sales by Country
3.7.2 Middle East and Africa Hydromorphone Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Hydromorphone Historic Market Analysis by Type
4.1 Global Hydromorphone Sales Market Share by Type (2016-2021)
4.2 Global Hydromorphone Revenue Market Share by Type (2016-2021)
4.3 Global Hydromorphone Price by Type (2016-2021)
5 Global Hydromorphone Historic Market Analysis by Application
5.1 Global Hydromorphone Sales Market Share by Application (2016-2021)
5.2 Global Hydromorphone Revenue Market Share by Application (2016-2021)
5.3 Global Hydromorphone Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Purdue Pharma
6.1.1 Purdue Pharma Corporation Information
6.1.2 Purdue Pharma Description and Business Overview
6.1.3 Purdue Pharma Hydromorphone Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Purdue Pharma Product Portfolio
6.1.5 Purdue Pharma Recent Developments/Updates
6.2 Akorn
6.2.1 Akorn Corporation Information
6.2.2 Akorn Description and Business Overview
6.2.3 Akorn Hydromorphone Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Akorn Product Portfolio
6.2.5 Akorn Recent Developments/Updates
6.3 Barr Pharmaceuticals
6.3.1 Barr Pharmaceuticals Corporation Information
6.3.2 Barr Pharmaceuticals Description and Business Overview
6.3.3 Barr Pharmaceuticals Hydromorphone Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Barr Pharmaceuticals Product Portfolio
6.3.5 Barr Pharmaceuticals Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Hydromorphone Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Pfizer Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Watson Laboratories
6.5.1 Watson Laboratories Corporation Information
6.5.2 Watson Laboratories Description and Business Overview
6.5.3 Watson Laboratories Hydromorphone Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Watson Laboratories Product Portfolio
6.5.5 Watson Laboratories Recent Developments/Updates
6.6 Mallinckrodt
6.6.1 Mallinckrodt Corporation Information
6.6.2 Mallinckrodt Description and Business Overview
6.6.3 Mallinckrodt Hydromorphone Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Mallinckrodt Product Portfolio
6.6.5 Mallinckrodt Recent Developments/Updates
6.7 Teva Pharmaceuticals
6.6.1 Teva Pharmaceuticals Corporation Information
6.6.2 Teva Pharmaceuticals Description and Business Overview
6.6.3 Teva Pharmaceuticals Hydromorphone Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Teva Pharmaceuticals Product Portfolio
6.7.5 Teva Pharmaceuticals Recent Developments/Updates
6.8 KV Pharmaceutical
6.8.1 KV Pharmaceutical Corporation Information
6.8.2 KV Pharmaceutical Description and Business Overview
6.8.3 KV Pharmaceutical Hydromorphone Sales, Revenue and Gross Margin (2016-2021)
6.8.4 KV Pharmaceutical Product Portfolio
6.8.5 KV Pharmaceutical Recent Developments/Updates
6.9 Lannett
6.9.1 Lannett Corporation Information
6.9.2 Lannett Description and Business Overview
6.9.3 Lannett Hydromorphone Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Lannett Product Portfolio
6.9.5 Lannett Recent Developments/Updates
6.10 Apotex
6.10.1 Apotex Corporation Information
6.10.2 Apotex Description and Business Overview
6.10.3 Apotex Hydromorphone Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Apotex Product Portfolio
6.10.5 Apotex Recent Developments/Updates
6.11 Fresenius
6.11.1 Fresenius Corporation Information
6.11.2 Fresenius Hydromorphone Description and Business Overview
6.11.3 Fresenius Hydromorphone Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Fresenius Product Portfolio
6.11.5 Fresenius Recent Developments/Updates
6.12 Johnson and Johnson
6.12.1 Johnson and Johnson Corporation Information
6.12.2 Johnson and Johnson Hydromorphone Description and Business Overview
6.12.3 Johnson and Johnson Hydromorphone Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Johnson and Johnson Product Portfolio
6.12.5 Johnson and Johnson Recent Developments/Updates
6.13 Mundipharma
6.13.1 Mundipharma Corporation Information
6.13.2 Mundipharma Hydromorphone Description and Business Overview
6.13.3 Mundipharma Hydromorphone Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Mundipharma Product Portfolio
6.13.5 Mundipharma Recent Developments/Updates
6.14 Novartis
6.14.1 Novartis Corporation Information
6.14.2 Novartis Hydromorphone Description and Business Overview
6.14.3 Novartis Hydromorphone Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Novartis Product Portfolio
6.14.5 Novartis Recent Developments/Updates
6.15 Stada Arzneimittel
6.15.1 Stada Arzneimittel Corporation Information
6.15.2 Stada Arzneimittel Hydromorphone Description and Business Overview
6.15.3 Stada Arzneimittel Hydromorphone Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Stada Arzneimittel Product Portfolio
6.15.5 Stada Arzneimittel Recent Developments/Updates
6.16 Mylan
6.16.1 Mylan Corporation Information
6.16.2 Mylan Hydromorphone Description and Business Overview
6.16.3 Mylan Hydromorphone Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Mylan Product Portfolio
6.16.5 Mylan Recent Developments/Updates
7 Hydromorphone Manufacturing Cost Analysis
7.1 Hydromorphone Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Hydromorphone
7.4 Hydromorphone Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Hydromorphone Distributors List
8.3 Hydromorphone Customers
9 Hydromorphone Market Dynamics
9.1 Hydromorphone Industry Trends
9.2 Hydromorphone Growth Drivers
9.3 Hydromorphone Market Challenges
9.4 Hydromorphone Market Restraints
10 Global Market Forecast
10.1 Hydromorphone Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Hydromorphone by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Hydromorphone by Type (2022-2027)
10.2 Hydromorphone Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Hydromorphone by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Hydromorphone by Application (2022-2027)
10.3 Hydromorphone Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Hydromorphone by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Hydromorphone by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer